Trump signs executive measures for pandemic relief, but effects are unclear.
President Trump took executive action this weekend that he said would extend an array of federal pandemic relief, while the United States reached yet another virus milestone: five million cases.
It was not clear, though, what immediate effect the orders he signed would have, if any, or what authority Mr. Trump has to act on his own. Under the Constitution, Congress has control over federal spending, and it appears likely that Mr. Trumps moves to circumvent Congress will be challenged in court.
Mr. Trump signed the orders billed as a federal eviction ban, a payroll tax suspension, relief for student borrowers and $400 a week for the unemployed at a news conference at his private golf club in New Jersey on Saturday. The orders did not include a number of provisions sought in congressional proposals, like aid to small businesses, school systems, and state and local governments.
The action came after two weeks of talks between White House officials and top congressional Democrats failed to reach agreement on a broad relief plan and temporary benefits provided under earlier aid measures expired with no resolution in sight.
Virus cases have surged in recent weeks, particularly in the Sun Belt states and in communities where officials moved quickly to reopen. But the nascent economic recovery from those reopenings has appeared to slow or stall in many areas. And schools across the country are grappling with how and whether to reopen in the fall.
According to a New York Times database, the U.S. leads the world in confirmed cases. Brazil ranks second, with more than three million confirmed cases, and India is third with two million. Public health experts have warned that the actual number of people infected is far greater. Brazil also reached a milestone of 100,000 deaths on Saturday.
At least 161,900 people infected with the virus have died in the U.S. since the pandemic began.
New Zealand on Sunday marked 100 days without any new reported cases of local transmission of the coronavirus, a major milestone as the pandemic continues to devastate countries across the world including neighboring Australia, where recent outbreaks have led to new lockdown measures in Melbourne and broader Victoria State.
New Zealand, a nation of five million people, reported in March that it had stamped out the virus after strict lockdown measures were implemented, and there has been no community transmission since, according to the countrys Health Ministry.
It has been 100 days since the last case of Covid-19 was acquired locally from an unknown source, the ministry said in a statement on Sunday. No additional cases are reported as having recovered, so there are still 23 active cases of Covid-19 in managed isolation facilities.
Public life has resumed for many people in the country, as they eat out at restaurants, socialize at bars, and attend sports and cultural events. However, some experts warn that letting down their guard now could lead to future outbreaks.
Achieving 100 days without community transmission is a significant milestone, said Dr. Ashley Bloomfield, the countrys top health official, said in a statement on Sunday. However, as we all know, we cant afford to be complacent.
We have seen overseas how quickly the virus can re-emerge and spread in places where it was previously under control, he said, and we need to be prepared to quickly stamp out any future cases in New Zealand.
Eight months ago, the new coronavirus was unknown. But to some human immune cells, it was already something of a familiar foe.
A flurry of recent studies has revealed that a large proportion of the population in some places, 20 to 50 percent of people might harbor immunity assassins called T cells that recognize the new coronavirus despite having never encountered it before.
These T cells, which lurked in the bloodstreams of people long before the pandemic began, are most likely stragglers from past scuffles with other related coronaviruses, including four that frequently cause common colds. Its a case of family resemblance: In the eyes of the immune system, germs with common roots can look alike, such that when a cousin comes to call, the body may already have an inkling of its intentions.
The presence of these T cells has intrigued experts, who say it is too soon to tell whether the cells will play a helpful, harmful or entirely negligible role against the current coronavirus.
But should these cross-reactive T cells exert even a modest influence on the bodys immune response, they might make the disease milder and perhaps partly explain why some people who catch the germ become very sick while others are dealt only a glancing blow.
Radhika Kumar goes to work every morning hoping to save lives. As a contact tracer for Los Angeles County, her job, at least on paper, entails phoning people who have tested positive for the coronavirus, along with others they may have exposed, and providing them with guidance on how to isolate so as not to infect others.
If that sounds easy, it is not.
To persuade people to cooperate, she has to get them to trust her. She has to convince them that they might be infected, even if they have no symptoms. She has to let people curse at her and hang up, then she has to call them back the next day.
And if she wants them to heed her advice, she has to listen, really listen, to how scared they are that if they stay home from their jobs, they might not be able to feed their families.
Sometimes it can really get to you, she said. The other day I had one young lady, and she was screaming on the phone, You dont understand I have three kids. I have to go to work.
I kept calling back and calling back, Ms. Kumar said. Im very relentless like that. I thought about it all night what am I going to do? I called her again first thing in the morning, and I was so relieved when she picked up.
Even as officials at the Centers for Disease Control and Prevention continue to tout the effectiveness of contact tracing, and state and local health agencies across the United States deploy new armies of tracers, tracking down everyone with the coronavirus is proving to be a Sisyphean task.
France is imposing a new requirement that people wear face masks outdoors in crowded areas of Paris and other major cities beginning on Monday as the number of coronavirus infections rises at the fastest rate since a national quarantine ended in mid-May.
The country had gotten the number of infections under control, but the pandemic is creeping back, with 2,288 new Covid-19 cases reported on Friday the third consecutive day of sharp increase. In the Paris Ile-de-France region, the rate of infections reached 2.4 percent on Friday, compared with a 1.6 percent national average.
The rise of new clusters has led the government to warn of the possibility of a second wave of infections in the autumn. In an effort to stem the spread of the virus, masks will now be mandatory for people age 11 and above in high-traffic areas, from the tourist havens of Saint Tropez and Biarritz to Pariss Seine river, Montmartre and other popular sites, as well as at outdoor food markets and in Pariss crowded suburbs.
The police will be enforcing the measures which will be in place for at least a month in Paris and are subject to review in other areas with a fine of 135 euros ($159).
The authorities are especially concerned about the popularity of free parties, that have seen hundreds of young people gather in the Parisien woods and other areas, often without wearing masks.
Wearing a mask in crowded enclosed spaces, including museums, shopping malls and on public transportation, has been compulsory in France since mid-July.
Tens of thousands of motorcyclists swarmed the streets of Sturgis, S.D., in the past few days for an annual rally, despite objections from residents and with little regard for the coronavirus.
The herds of people driving recreational vehicles, bikes and classic cars overran every street in town, making little or no effort to keep six feet apart. Few masks could be seen, and free bandannas being passed out were mostly folded, or wrapped around peoples heads.
With temperatures in the low 80s and not much cloud cover, many people sought shade under shopping tents where Screw Covid shirts were sold.
The Sturgis Motorcycle Rally, a 10-day affair that began Friday, is expected to attract roughly 250,000 enthusiasts this year about half the number who attended last year, but a figure that puts it on track to be among the countrys largest public gatherings since the first coronavirus cases emerged.
South Dakota is one of several states that did not impose a lockdown, and state officials have not required residents to wear masks.
Health experts say the coronavirus is less likely to spread outdoors, especially when people wear masks and socially distance. But large gatherings also increase the number of visitors inside restaurants and stores.
A few businesses in Sturgis put up signs limiting the number of customers who could enter, but most did not.
Over the past week, South Dakota has reported an average of 87 new coronavirus cases per day. At least two new virus deaths and 106 new cases were reported on Saturday.
In 2009, when H1N1, better known as swine flu, was stoking fears of a devastating pandemic, a small biotech company named Inovio Pharmaceuticals rushed to create a vaccine. After announcing promising early results, the companys stock soared more than 1,000 percent.
In the years since, Inovio has announced encouraging news about its work on vaccines for malaria, the Zika virus and even a cancer vaccine. The declarations have caused the companys stock price to leap, enriching investors and senior executives.
There is a catch, though: Inovio has never brought a vaccine to market.
Now, Inovio is working on a vaccine for the coronavirus, and a flurry of positive news releases about its funding and preliminary results have helped the company attract money from the U.S. government and investors.
But some scientists and financial analysts question the viability of Inovios technology. While there are some early signs of promise with its vaccine, Inovio has released only bare-bones data from the first phase of clinical trials. It is locked in a legal battle with a key manufacturing partner that claims Inovio stole its technology.
And while the company has said that it is part of Operation Warp Speed the flagship federal effort to quickly produce treatments and vaccines for the coronavirus Inovio is not on the list of companies selected to receive financial support to mass-produce vaccines.
The absence of that funding, coupled with their ongoing litigation, coupled with the need to scale a device, coupled with the absence of complete Phase 1 data, makes people skeptical, said Stephen Willey, an analyst at Stifel, an investment firm.
Inovio could provide an update on its progress with the vaccine when it releases its second-quarter financial results on Monday.
Saudi Aramco, the worlds largest oil company, said on Sunday that its quarterly earnings had plunged more than 73 percent compared with a year ago, as lockdowns imposed to curb the pandemic drastically cut the demand for oil. Despite the steep fall in earnings, to $6.6 billion from $24.7 billion, the company said it would continue paying a quarterly dividend of $18.75 billion nearly all of which will go to the Saudi government.
At least nine people were killed after a fire broke out on Sunday at a hotel in southern India that was being used as a makeshift facility for Covid-19 patients, officials said.
The fire, in the city of Vijayawada, occurred at the Swarna Palace hotel, which was being used to shelter and treat people who had tested positive for the coronavirus.
The police attributed the accident to a short circuit in an air-conditioner on the ground floor. After the blaze broke out early Sunday, panicked patients jumped from balconies on the upper floors and several were injured, according to local news media outlets.
After most of Indias coronavirus restrictions were lifted in recent weeks, infections have surged, leading some states to move patients into hotels and other makeshift health facilities. As of Sunday, Indias health ministry had reported more than two million total infections and nearly 45,000 deaths.
Despite surging coronavirus transmission rates around the United States, the N.F.L. contends that its season will begin, as scheduled, on Sept. 10. But 68 players have opted out of playing, according to the league.
They represent a microcosm of N.F.L. rosters: rookies and veterans, practice-squadders and starters, all of whom decided to lessen one risk while absorbing another. To keep themselves and their families safer, they will sacrifice the chance to compete for a Super Bowl, forgo showcasing themselves for more lucrative contracts and, in some cases, cede starting jobs and roster spots that may or may not be there next season.
Half of the players who opted out are offensive and defensive linemen, who are in closest contact with other players during practices and games. Leo Koloamatangi, an offensive lineman on the Jets who opted out, said he was resigned to contracting the virus had he chosen to play.
Where I play, Im literally bear-hugging another creature on the other side of the ball every single play, Koloamatangi, 26, said in an interview. If that guy has any symptoms, Im going to get them. He added, For myself, I couldnt take those chances.
Koloamatangi said he knew it was unfeasible for the N.F.L. to enter a bubble, as the N.B.A. and N.H.L. have. But he wondered why the N.F.L. had not pushed back camp and the season, or introduce additional safety measures such as gloves, or helmets with masks that would further mitigate his risk of infection.
As it stands, the N.F.L.s testing protocol calls for players to be tested every day for the first two weeks of training camp, and then every other day after that.
Reporting was contributed by Liz Alderman, David Gelles, Heather Murphy, Stanley Reed, Ben Shpigel, Derrick Taylor, Mark Walker, Katherine J. Wu and Ceylan Yeginsu.
Go here to read the rest:
- Top Benefits of Stem Cell Therapy Know Your Health - September 26th, 2020
- 10 Benefits of a Stem Cell Treatment | Advanced Sports ... - September 26th, 2020
- New Data Highlights BeyondSpring's Plinabulin as a Highly Effective Agent for Preventing Chemotherapy-Induced Neutropenia, with Potential to Reduce... - September 26th, 2020
- Virtual Castellvi Spine Week 2: Living Cells and Therapies - https://ryortho.com/ - September 26th, 2020
- Get Up to Speed On the State of Eco-Fashion - NEO.LIFE - September 26th, 2020
- Global Cell Culture Market and Technology Forecast 2020-2028 - Global Market Forecast to Reach USD 48 Billion for 2028 - ResearchAndMarkets.com -... - September 24th, 2020
- Advances in the Treatment of Mantle Cell Lymphoma are Greatly Improving the Long-Term Outlook for Patients - Curetoday.com - September 24th, 2020
- Global Cord Blood Banking Market is Anticipate to Reach at a CAGR of 5.5% during the forecast period - PharmiWeb.com - September 24th, 2020
- CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to... - September 24th, 2020
- Lab-grown meat: The promising alternative that may be years away from appearing on dinner plates - PitchBook News & Analysis - September 24th, 2020
- Bioprinted therapeutic offers novel solution for treating Type 1 Diabetes - Canada NewsWire - September 24th, 2020
- Yulong to List its Securitized Token on CryptoSX - BioSpace - September 24th, 2020
- 10 Top Stem Cell Companies on the NASDAQ | INN - Investing News Network - September 22nd, 2020
- The Anti-aging Benefits of Using Growth Factors Plus Retinol - Coveteur - September 22nd, 2020
- Alexion Receives CHMP Positive Opinion for New Advanced Formulation of ULTOMIRIS (ravulizumab) with Significantly Reduced Infusion Time - Business... - September 22nd, 2020
- Why Celebs and Athletes Are Embracing Blood Flow Restriction Training - menshealth.com - September 22nd, 2020
- Yulong to Issue the Worlds' First Biotech Securitized Token Offering - StreetInsider.com - September 22nd, 2020
- Market trends and outlook coupled with factors driving and restraining the growth of the CRISPR Genome Editing market - The Daily Chronicle - September 22nd, 2020
- COVID is shifting the conversation about the medical application of CBD - Open Access Government - September 22nd, 2020
- Merck's KEYTRUDA (pembrolizumab) Reduced the Risk of Distant Metastasis or Death by 40% Versus Placebo as Adjuvant Treatment in Resected, High-Risk... - September 22nd, 2020
- Regenerative Therapy by Dr. Roshni Patel on Better CT - Farmington, CT - Patch.com - September 20th, 2020
- Four-Year Data Continue to Show Superior, Long-Term Survival Benefit with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in Patients with Previously... - September 20th, 2020
- The Top 10 Biotech Companies Brewing at... - Labiotech.eu - September 18th, 2020
- CRISPR Market to Witness Exponential Growth by 2020-2027 | Leading Players Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR... - September 18th, 2020
- Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation - nejm.org - September 18th, 2020
- Frequency Therapeutics Presents Results Demonstrating Sustained Improvement in Hearing Loss Patients Treated with FX-322 - Business Wire - September 18th, 2020
- Faulty exon splicing is cause of rare subtype of Parkinson's disease, pointing to new drug targets - BioWorld Online - September 15th, 2020
- Treating dogs diagnosed with GBM, getting Swedish patients back to work, orphan designation for improved radiotherapy drug plus gene therapy - Brain... - September 13th, 2020
- Histogen Announces Completion of Dosing Milestone in its 1b/2a Trial for Androgenic Alopecia in Men - StreetInsider.com - September 13th, 2020
- BeyondSpring (BYSI) Receives Breakthrough Therapy Designations from Both US FDA and China NMPA for Plinabulin in Chemotherapy-Induced Neutropenia... - September 8th, 2020
- Hematopoietic Stem Cells (HSCs) Market 2020: Potential Growth, Challenges, and Know the Impact of COVID-19 on Industry | Key Players: Kite Pharma... - September 8th, 2020
- Stem Cell Therapy Market Scope and Opportunities Analysis 2017 2025 - StartupNG - August 31st, 2020
- Im Optimistic That We Will Have a COVID-19 Vaccine Soon - The Atlantic - August 31st, 2020
- Health insurance with maternity cover: All you need to know about features and inclusions - CNBCTV18 - August 31st, 2020
- Emerging Treatment Options of Regenerative Medicine in Severe Corona Virus/COVID 19 Infections - DocWire News - August 31st, 2020
- MaaT Pharma Announces Positive Data for Its Lead Microbiome Biotherapeutic MaaT013 in Intestinal Acute Graft-versus-Host-Disease at the Virtual 46th... - August 31st, 2020
- Exosome Therapeutic Market 2020-2026 is Growing So Rapidly || Leading Players THERAPEUTICS, EXOCOBIO, Exopharm, AEGLE Therapeutics, United... - August 20th, 2020
- Inside the race to ditch formula and grow breast milk in the lab - Wired.co.uk - August 20th, 2020
- Animal Stem Cell Therapy Market: Rising Demand and Growth Opportunity - Owned - August 20th, 2020
- Health Spotlight: Have You Heard Of Dr. Jeffrey Tucker? - LATF USA - August 20th, 2020
- Viruses have big impacts on ecology and evolution as well as human health - The Economist - August 20th, 2020
- Merck's KEYTRUDA (pembrolizumab) in Combination With Chemotherapy Significantly Improved Overall Survival and Progression-Free Survival Compared With... - August 20th, 2020
- Umbilical cord blood banking: Is it worth it? - mtltimes.ca - August 19th, 2020
- G1 Therapeutics Announces Acceptance and Priority Review of NDA for Trilaciclib for Patients with Small Cell Lung Cancer - GlobeNewswire - August 19th, 2020
- A question of scale the growing pains of cell-based meat - just-food.com - August 19th, 2020
- What do we need to know about our bone health during this pandemic - Times of India - August 19th, 2020
- Researcher John Craig Venter Is Awarded the 2020 Edogawa-NICHE Prize for His Accomplishment in Human Genome Research - Business Wire India - August 19th, 2020
- Cellect Biotechnology Ltd ADR (NASDAQ:APOP) Receives an Approval of a Pivotal Patent for Stem Cells Activation from the European Patent Office - BP... - August 13th, 2020
- A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeuticrelated cytokine release syndrome - Wiley - August 13th, 2020
- Autologous Stem Cell Based Therapies Industry Market 2020 Explain What is the current size of the market? And key players analysis: Athersys,... - August 13th, 2020
- Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL - OncLive - August 11th, 2020
- CELLECTAR BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com - August 11th, 2020
- Trumps Unprecedented Attacks on Our Public-Health System - The New Yorker - August 11th, 2020
- New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 - PharmiWeb.com - August 11th, 2020
- The NIU BODY Rebrand: millennials have grown up and so has their skin care - CosmeticsDesign.com USA - August 11th, 2020
- Embryos could be susceptible to COVID-19 from second week of pregnancy - Gulf News - August 9th, 2020
- How to live longer: The health drink that reduces risk of Alzheimers and boosts longevity - Express - August 9th, 2020
- The global cell and gene therapy market by revenue is expected to grow at a CAGR of over 30.90% during the period 20192025 - GlobeNewswire - August 5th, 2020
- Research Report on Cell Theraputics Market by Current Industry Status, Growth Opportunities, Top Key Players, and Forecast to 2025 - AlgosOnline - August 5th, 2020
- Pediatrics in Brevard: Nothing beats the benefits of breastmilk for newborns - Florida Today - August 5th, 2020
- How can nanomedicine be applied to cannabis? - Leafly - August 5th, 2020
- Cell Expansion Market Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2027 - CueReport - August 5th, 2020
- FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative - Endpoints News - August 5th, 2020
- Fighting for a life unlimited with the Cystic Fibrosis Trust - Health Europa - August 5th, 2020
- World Breastfeeding Week 2020: The Benefits Of Breastfeeding For Mother And Baby - News18 - August 5th, 2020
- Stem Cells Cryopreservation Equipments Market to grow significantly in future | Worthington Industries,Cesca Therapeutics,Shengjie Cryogenic Equipment... - August 3rd, 2020
- Stem Cell Therapy Market Latest Trends, Development, Revenue, Demand And Forecast To 2022 - Market Research Correspondent - August 3rd, 2020
- Global trade impact of the Coronavirus Synthetic Stem Cells Market Report 2020-2026 Research Insights 2020 Global Industry Outlook Shared in Detailed... - July 30th, 2020
- World's First Plant and Cell Based Bacon and Pork Belly - One Green Planet - July 30th, 2020
- FDA Approves New CAR-T Therapy for Mantle Cell Lymphoma - Cancer Health Treatment News - July 26th, 2020
- Of mice and SARS-CoV-2 - The Hindu - July 26th, 2020
- Ruxolitinib passes another PhIII test for graft-versus-host disease, a win for Incyte and Novartis - Endpoints News - July 24th, 2020
- Study finds the real reason you get goosebumps - Big Think - July 24th, 2020
- Harvard study finds that stem cell stimulation gives us goosebumps - New Atlas - July 24th, 2020
- Celltex Therapeutics Webinar | Houston, TX Patch - Patch.com - July 24th, 2020
- Bioreactors Market Forecast to 2027 Covid-19 Impact and Global Analysis by Product Class, Material, Cell ; Molecule ; Technology ; End User, and... - July 24th, 2020
- Association of TNF- Gene Expression and Release in Response to | DMSO - Dove Medical Press - July 24th, 2020
- 'Missing link': Bayer, Morningside help catapult a new kind of delivery tech to cell and gene therapy - Endpoints News - July 24th, 2020
- Regulation of advanced therapy medicinal products in the EU - Regulatory Focus - July 18th, 2020
- Coronavirus Drug and Treatment Tracker - The New York Times - July 18th, 2020